Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-031039
Filing Date
2025-08-14
Accepted
2025-08-14 07:53:35
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20050513_10q.htm   iXBRL 10-Q 925384
7 EXHIBIT 31.1 ef20050513_ex31-1.htm EX-31.1 14441
8 EXHIBIT 31.2 ef20050513_ex31-2.htm EX-31.2 12755
9 EXHIBIT 32.1 ef20050513_ex32-1.htm EX-32.1 7785
10 EXHIBIT 32.2 ef20050513_ex32-2.htm EX-32.2 8020
  Complete submission text file 0001140361-25-031039.txt   5750910

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA galt-20250630.xsd EX-101.SCH 47577
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE galt-20250630_def.xml EX-101.DEF 286207
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE galt-20250630_lab.xml EX-101.LAB 457004
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE galt-20250630_pre.xml EX-101.PRE 294654
6 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT galt-20250630_cal.xml EX-101.CAL 30128
76 EXTRACTED XBRL INSTANCE DOCUMENT ef20050513_10q_htm.xml XML 660876
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 251214399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)